Anti-Borreliella burgdorferi ospA Antibody (SAA2243)

Anti-Borreliella burgdorferi ospA Antibody (SAA2243)

A powerful tool for your biotech research needs.

This highly specific antibody targets the outer surface protein A (OspA) of the Borreliella burgdorferi bacterium, the causative agent of Lyme disease. It is a monoclonal antibody that has been extensively validated for its high affinity and specificity towards OspA.

Biological Function

The Anti-Borreliella burgdorferi ospA Antibody (SAA2243) works by binding to the OspA protein, preventing its interaction with host cells and inhibiting the bacterium’s ability to cause infection. This makes it an essential tool for studying the pathogenesis of Lyme disease and developing potential treatments.

Main Applications

This antibody is ideal for use in various applications, including Western blotting, ELISA, immunohistochemistry, and flow cytometry. It has been successfully used in both in vitro and in vivo studies, providing reliable and reproducible results.

Experimental Use Cases

The Anti-Borreliella burgdorferi ospA Antibody (SAA2243) has been used in numerous research studies to investigate the role of OspA in Lyme disease. It has been shown to effectively block the transmission of the bacterium from ticks to host animals, providing crucial insights into the disease’s pathogenesis. Additionally, it has been used to study the immune response to OspA and its potential as a vaccine candidate.

With its high specificity and versatility, this antibody is a valuable tool for any researcher studying Lyme disease and its causative agent, Borreliella burgdorferi.

In summary, the Anti-Borreliella burgdorferi ospA Antibody (SAA2243) offers a reliable and effective means of targeting OspA in various research applications. Its proven track record in numerous studies makes it a top choice for scientists looking to advance their understanding of Lyme disease. Order yours today and take a step towards groundbreaking discoveries in biotech research.